“Shelly” Xiaolu Pan is a graduate student at the University of North Carolina at Chapel Hill. She earned her MD from Guizhou Medical University in China in 2012. Xiaolu Pan then joined the University of Texas MD Anderson Cancer Center for basic research training, earning an MS degree in Genetics and Cancer Biology in 2015. Her thesis research under the supervision of Dr. Xin Lu and Dr. Ronald DePinho led to the identification of prostate cancer–driver genes using high-throughput functional genomics (co-first author, Cancer Res 2018). Driven by an interest in applying genetics to personalized medicine, Xiaolu Pan transitioned to cardiovascular research in Xander Wehrens’s lab at Baylor College of Medicine to focus on gene therapy of inherited arrhythmia syndromes using the CRISPR/Cas9 system(co-first author. Circ Res 2018). Currently, Xiaolu Pan joined Dr. Jonathan Serody’s Lab at UNC Chapel Hill to study cancer immunology. She has an intensive interest in cancer research.
Xiaolu "Shelly" Pan, M.S.
